Dividend increase AbbVie (ABBV) – 2019
Last week a new dividend increase of one of the stocks of my Vrijheid Fonds was published. On November 1st AbbVie (ABBV) announced a 10.3% increase in its quarterly dividend. The dividend is raised from $1.07 to $1.18. The dividend pay date is February 14, 2020 to shareholders of record on January 15, 2020 (ex-dividend January 14, 2020).
Richard A. Gonzalez, chairman and chief executive officer of AbbVie, said: “Strong performance from our Immunology and Hematologic Oncology portfolios led our growth this quarter. We are also making excellent progress with several key strategic priorities, including the recent launch of our two new immunology therapies – Rinvoq and Skyrizi – both of which are off to an impressive start, as well as continued progress toward the completion of our planned acquisition of Allergan. Based on the continued momentum of our portfolio, we are once again raising our full year 2019 EPS guidance range and increasing our dividend”
The new dividend amount represents an annualized dividend amount of $4.72 per share, up from $4.28. The dividend yield on current price is 5.37 %.
My Vrijheid Fonds consist of 44 shares of ABBV, my annual dividends will increase by €14.74 ($16.46) after taxes. For 2019 my dividends will not change. My projected annual total amount from my shares of ABBV will be €158.08 after taxes.
This I my first dividend increase of ABBV ever. And I love these kinds of increases! Let’s hope that AbbVie will continue to delight us with these kinds of increases.